← All indications
Weight Gain
Increase in BODY WEIGHT over existing weight.
Subtype terms (2)
More specific conditions that are subtypes of Weight Gain in the MeSH hierarchy.
Drugs by status
Phase 4 trials (16)
Phase 3 trials (10)
Phase 2 trials (7)
Phase 1 trials (3)
Organizations
Organization Involved with Phase 4 Indications (31)
- Amylin
- Eisai
- Merck
- Eli Lilly
- Pfizer
- Genovate Biotechnology Co., Ltd.,
- AIDS Clinical Trials Group
- National Institute of Allergy and Infectious Diseases (NIAID)
- National Institute of Mental Health (NIMH)
- Central South University
- Baylor University
- Beer Yaakov and Ness Ziona Mental Health Center
- Case Western Reserve University
- Chang Gung University
- Johns Hopkins University
- Northwell Health
- The Zucker Hillside Hospital
- Tuscaloosa Research & Education Advancement Corporation (TREAC)
- University of Maryland
- University of Toronto
- University of Bern
- Columbia University
- University of Cincinnati
- University of Copenhagen
- Vanderbilt University
- Janssen Pharmaceutica NV
- University of North Carolina at Chapel Hill
- Department of Veteran Affairs
- University of Western Ontario
- Government of Singapore
- +1 more
Organization Involved with Phase 3 Indications (14)
- AstraZeneca
- National Institutes of Health (NIH)
- National Institute on Drug Abuse (NIDA)
- Medical University of Graz
- Ain Shams University
- Cornell University
- Ohio State University
- Mayo Clinic
- University of Vienna
- Winthrop University
- University of Tuebingen
- Society of Family Planning
- CenTrial GmbH
- Prader Willi Syndrome Association
Organization Involved with Phase 2 Indications (26)
- Corcept Therapeutics
- Endo Pharmaceuticals
- Nutrition 21, Inc.
- OBEcure Ltd.
- Orexigen Therapeutics, Inc
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- New York University
- Singapore General Hospital
- Stanley Medical Research Institute
- University of Alberta
- Yale University
- State University of New York
- University of Calgary
- University of California, Irvine
- GW Research
- Atlanta Center for Medical Research
- Florida Clinical Research Center, LLC
- CNRI-LA, Pico Rivera CA
- State University of New York, Syracuse
- Brooklyn Medical Institute
- Larue D. Carter Hospital
- American Medical Research
- Synergy Research
- Foundation of Hope, North Carolina
- SingHealth Investigational Medicine Unit
- IQVIA
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (15)
- GlaxoSmithKline
- Supplement Formulators, Inc.
- National Institute on Aging (NIA)
- Dr. Sami Ulus Children's Hospital
- Stanford University
- University of North Dakota
- University of South Carolina
- University of Colorado, Denver
- Medical University of South Carolina
- Dr Sami Ulus Research and Training Hospital
- University of Oxford
- Neuropsychiatric Research Institute, Fargo, ND
- Clasado Biosciences
- China Medical University
- LIfe Extension